<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2019.910187</article-id><article-id pub-id-type="publisher-id">ACM-32645</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20191000000_34077178.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  肺动脉瓣上消融治疗右心室流出道室性心律失常的临床研究
  Clinical Research on Ablation of Ventricular Arrhythmias Originating from Right Ventricular Outflow Tract via Above Pulmonary Valve
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>小青</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>卫明</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>梦非</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>朱</surname><given-names>帧燕</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>常州市第一人民医院心内科，江苏 常州</addr-line></aff><aff id="aff2"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>27</day><month>09</month><year>2019</year></pub-date><volume>09</volume><issue>10</issue><fpage>1213</fpage><lpage>1221</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   目的：探讨肺动脉瓣上倒“U”法与传统肺动脉瓣下方法消融起源于右心室流出道(right ventricular outflow tract, RVOT)室性心律失常(Vas)的有效性及安全性。方法：常州市第一人民医院心内科2017年09月至2019年01月143例室性心律失常患者行电生理检查(EPS)及射频消融术(RFCA)，其中86例患者经标测明确为RVOT起源的室性早搏(室早，PVC)/室性心动过速(室速，VT)，分为两组，一组55例患者经传统肺动脉瓣下途径消融，另一组31例患者采用倒“U”法至肺动脉瓣上消融，观察两组之间电生理标测、消融结果及并发症发生率。结果：传统消融组需平均放电4.3 &#177; 1.7次，有效放电后室早在5.7 &#177; 3.4秒消失，倒“U”法消融组平均放电1.8 &#177; 0.6次，有效放电后室早在2.8 &#177; 1.9秒消失(P &lt; 0.01)。传统消融组成功率85.45% (47/55)，倒“U”法消融组成功率96.77% (30/31)，成功率有显著差异(P &lt; 0.01)。传统消融组8例瓣下消融未成功者同次手术中采用倒“U”法至瓣上消融后7例成功。传统消融组心脏压塞1例，倒“U”组无并发症发生。结论：与传统消融方法比较，经倒“U”法至肺动脉瓣上消融，放电次数减少，达效时间(Time to Effect, TTE)更短，成功率增加，安全性更好。 Objective: To evaluate the efficacy and safety of ablation of ventricular arrhythmias (VAs) origi-nating from right ventricular outflow tract (RVOT) using innovative method of reversed U curve and conventional method with subvalvular approach. Methods: Electrophysiological study (EPS) and radiofrequency catheter ablation (RFCA) were performed on 143 patients with premature ventricular contractions (PVCs)/ventricular tachycardia (VT) in Changzhou first people’s hospital from September 2017 to January 2019. Among them, 86 patients were diagnosed as PVC/VT originating from RVOT, and they were divided into two groups. One group including 55 cases were ablated with conventional method via subvalvular approach, and the other group including 31 cases just with the moulding of reversed U curve above the pulmonary valve. The differences in the activation mapping, results of ablation and the incidence of complications between two groups were observed. Results: The conventional ablation group had 4.3 &#177; 1.7 times of radiofrequency (RF) on average compared with 1.8 &#177; 0.6 times in the reversed U curve group (P &lt; 0.01). After radiofrequency (RF) delivered, the PVCs in conventional group disappeared in 5.7 &#177; 3.4 seconds, while those in reversed U curve ablation group were gone in 2.8 &#177; 1.9 seconds (P &lt; 0.01). The success rate of ablation in the reversed U curve ablation group was 96.77% (30/31), which was different from the other group, 85.45% (47/55) (P &lt; 0.01). In the conventional group, ablation was failed in 8 cases, and then the failed cases were performed with reversed U curve ablation. As a result, ablation was successful in 7 cases. There was one case of cardiac tamponade in the conventional ablation group with the ablation target located in the free wall of the RVOT, and no complications occurred in another group. Conclusion: Contrasted with conventional ablation group, the times of RF in the reversed U curve group are fewer, the Time to Effect (TTE) of ablation is shorter, the success rate is increased, and the safety is higher. 
  
 
</p></abstract><kwd-group><kwd>室性心律失常，流出道，射频消融, Ventricular Arrhythmias</kwd><kwd> Outflow Tract</kwd><kwd> Radiofrequency Catheter Ablation</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>肺动脉瓣上消融治疗右心室流出道室性心律失常的临床研究<sup> </sup></title><p>王小青，王卫明，王梦非，朱帧燕</p><p>常州市第一人民医院心内科，江苏 常州</p><p><img src="//html.hanspub.org/file/16-1571057x1_hanspub.png" /></p><p>收稿日期：2019年9月25日；录用日期：2019年10月17日；发布日期：2019年10月24日</p><disp-formula id="hanspub.32645-formula36"><graphic xlink:href="//html.hanspub.org/file/16-1571057x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>目的：探讨肺动脉瓣上倒“U”法与传统肺动脉瓣下方法消融起源于右心室流出道(right ventricular outflow tract, RVOT)室性心律失常(Vas)的有效性及安全性。方法：常州市第一人民医院心内科2017年09月至2019年01月143例室性心律失常患者行电生理检查(EPS)及射频消融术(RFCA)，其中86例患者经标测明确为RVOT起源的室性早搏(室早，PVC)/室性心动过速(室速，VT)，分为两组，一组55例患者经传统肺动脉瓣下途径消融，另一组31例患者采用倒“U”法至肺动脉瓣上消融，观察两组之间电生理标测、消融结果及并发症发生率。结果：传统消融组需平均放电4.3 &#177; 1.7次，有效放电后室早在5.7 &#177; 3.4秒消失，倒“U”法消融组平均放电1.8 &#177; 0.6次，有效放电后室早在2.8 &#177; 1.9秒消失(P &lt; 0.01)。传统消融组成功率85.45% (47/55)，倒“U”法消融组成功率96.77% (30/31)，成功率有显著差异(P &lt; 0.01)。传统消融组8例瓣下消融未成功者同次手术中采用倒“U”法至瓣上消融后7例成功。传统消融组心脏压塞1例，倒“U”组无并发症发生。结论：与传统消融方法比较，经倒“U”法至肺动脉瓣上消融，放电次数减少，达效时间(Time to Effect, TTE)更短，成功率增加，安全性更好。</p><p>关键词 :室性心律失常，流出道，射频消融</p><disp-formula id="hanspub.32645-formula37"><graphic xlink:href="//html.hanspub.org/file/16-1571057x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2019 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/16-1571057x7_hanspub.png" /> <img src="//html.hanspub.org/file/16-1571057x8_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>特发性室性心律失常(ventricular arrhythmias, Vas)包括室性早搏(室早，PVC)和室性心动过速(室速，VT)，常发生于无器质性心脏病患者 [<xref ref-type="bibr" rid="hanspub.32645-ref1">1</xref>]，心室流出道为其最常见的好发部位 [<xref ref-type="bibr" rid="hanspub.32645-ref2">2</xref>]。射频消融对频发、症状严重并且药物无效VAs的疗效已得到证实 [<xref ref-type="bibr" rid="hanspub.32645-ref3">3</xref>]。消融右心室流出道(RVOT)室早/室速，传统方法是经肺动脉瓣下途径，Liao等 [<xref ref-type="bibr" rid="hanspub.32645-ref4">4</xref>] 提出RVOT室早/室速绝大多数起源于肺动脉瓣上即肺动脉窦内，使用倒“U”法至肺动脉窦内标测及消融达到100%成功率。陈海敏等 [<xref ref-type="bibr" rid="hanspub.32645-ref5">5</xref>] 提出消融RVOT起源室早/室速，倒“U”方法比传统方法更具优势。本文回顾性分析了86例RVOT-VAs患者的临床资料，剖析和对比倒“U”方法与传统途径的有效性和安全性，以提高标测消融成功率，降低消融风险。</p></sec><sec id="s4"><title>2. 资料和方法</title><sec id="s4_1"><title>2.1. 研究对象</title><p>常州市第一人民医院心内科2017年09月至2019年01月143例室早/室速患者行RFCA，其中86例患者经标测明确为RVOT起源的PVC/VT，男39例，年龄15~73 (52.61 &#177; 16.82)岁。术前均行24 h动态心电图检查，PVC总数l0,048~41,852 (22,584 &#177; 11,721)次/24h。所有患者均符合快速性心律失常消融适应证 [<xref ref-type="bibr" rid="hanspub.32645-ref6">6</xref>]。入选标准：1) 无器质性心脏病，室早频发(&gt;10,000次/24 h，室早负荷 &gt; 10%)或持续性室速；2) 心电图提示RVOT起源：II、III、aVF导联QRS波呈高大R波。胸导联为左束支阻滞图形，胸导联移行 ≥ V3；3) 症状明显，口服抗心律失常药物治疗无效。排除标准：1) 严重心肺、肝肾功能不良及凝血功能障碍不能耐受手术；2) 合并病毒性心肌炎或心肌梗死 &lt; 6个月；3) 胸廓严重畸形；4) 高龄(&gt;85岁)。消融术前停服抗心律失常药物至少5个半衰期，签署知情同意书后接受电生理检查及射频消融术。该研究符合2013年修订的《赫尔辛基宣言》的要求。</p></sec><sec id="s4_2"><title>2.2. 电生理检查和消融</title><p>穿刺右股静脉，送入3.5 mm冷盐水灌注导管(NaviStar ThermoCool, Biosense Webster)至RVOT，在Carto3系统下行激动标测，如局部靶点电位较VAs的QRS波提早25 ms以上，为试消融靶点。功率控制消融，消融功率30 W，盐水灌注17 mL/min。传统组先于瓣下标测消融，若多次尝试消融无效，则将消融导管倒“U”至肺动脉窦内进一步标测。倒“U”组经初步标测判断为RVOT起源的VAs后直接至肺动脉窦内标测消融(见图1、图2)。判定靶点在肺动脉瓣上的指标：1) X线影像学位置；2) 三维解剖模型；3) 靶点图可见小A波和大V波。成功标准 [<xref ref-type="bibr" rid="hanspub.32645-ref7">7</xref>] ：即刻成功标准：术后基线状态下及异丙肾上腺素静脉滴注后，观察半小时VAs消失；远期成功标准：术后3月复查动态心电图，VAs负荷减少75%以上。根据随访结果，比较分析两组之间电生理标测、消融结果及并发症发生率。</p></sec></sec><sec id="s5"><title>3. 统计学处理</title><p>计量资料采用(x &#177; s)表示，使用t检验分析是否存在差异。计数资料以例数和百分率(%)表示，组间比较采用r检验或Fisher确切概率法直接计算概率。P &lt; 0.05为差异有统计学意义。</p></sec><sec id="s6"><title>4. 结果</title><sec id="s6_1"><title>4.1. 消融结果(见表1)</title><p>1) 放电次数：传统消融组需平均放电4.3 &#177; 1.7次，倒“U”法消融组平均放电1.8 &#177; 0.6次(P &lt; 0.01)。</p><p>2) 达效时间(Time to Effect, TTE)：定义为射频电流发放后至VAs消失或终止的时间。传统消融组TTE为5.7 &#177; 3.4秒，倒“U”法消融组则为2.8 &#177; 1.9秒(P &lt; 0.01)。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Comparison of ablation results between conventional method and reversed U curve metho</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >项目</th><th align="center" valign="middle" >传统法消融组</th><th align="center" valign="middle" >倒“U”法消融组</th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >n</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >放电次数(次)</td><td align="center" valign="middle" >4.3 &#177; 1.7</td><td align="center" valign="middle" >1.8 &#177; 0.6</td><td align="center" valign="middle" >P &lt; 0.01</td></tr><tr><td align="center" valign="middle" >达效时间(秒)</td><td align="center" valign="middle" >5.7 &#177; 3.4</td><td align="center" valign="middle" >2.8 &#177; 1.9</td><td align="center" valign="middle" >P &lt; 0.01</td></tr><tr><td align="center" valign="middle" >成功率</td><td align="center" valign="middle" >47 (85.45%)</td><td align="center" valign="middle" >30 (96.77%)</td><td align="center" valign="middle" >P &lt; 0.01</td></tr><tr><td align="center" valign="middle" >并发症</td><td align="center" valign="middle" >1 (1.8%)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>表1. 传统法及倒“U”法的消融结果比较[n (%)]</p><p>3) 成功率：随访时间为(4~20)月，传统消融组成功率85.45% (47/55)，倒“U”组成功率96.77% (30/31)，倒“U”组成功率显著高于传统组(P &lt; 0.01)。传统消融组8例瓣下消融未成功者同次手术中采用倒“U”法至瓣上消融后7例成功。</p></sec><sec id="s6_2"><title>4.2. 并发症</title><p>传统消融组心包填塞1例，于右室流出道游离壁反复消融时发生。倒“U”组无并发症发生。</p><p>患者，男，28岁，因“反复心悸2年，加重1月”入院。(a) 体表心电图：V1导联呈rS型，胸前导联R波在V3~V4移行，I呈r型，II、III、aVF导联均为高大R波，AVR及AVL导联为QS型。(B) RAO 30&#176;消融影像。(c) 腔内图：早搏时靶点局部V波前有一碎裂低幅电位，领先体表QRS波50 ms。(d) (e)分别为RL及RAO体位三维影像，粉红点代表靶点，提示位于肺动脉右窦。黄色点为希氏束RL = 右侧位；RAO = 右前斜。</p><p>图1. 倒“U”法消融1例起源于肺动脉右窦的室性早搏</p><p>患者，男，66岁，因“心悸半年”入院。(a) 体表心电图：V1导联呈rS型，胸前导联R波移行于V3，I呈rS型，II、III、aVF导联均为高大R波，AVR、AVL导联为QS型。(b) RAO 30&#176;X线影像。(c) 腔内图：早搏时靶点局部V波领先体表QRS波32 ms，单极导联呈QS型。(d) (e)分别为LL位及PA位三维影像，粉红点代表靶点，提示位于肺动脉左窦。蓝色点为希氏束RAO (右前斜)；LL (左侧位)；PA (后前位)。</p><p>图2. 倒“U”法消融1例起源于肺动脉左窦的室性早搏</p></sec></sec><sec id="s7"><title>5. 讨论</title><p>心肌与血管的交界处组织相互移行，电生理基质不均一，使心脏流出道容易发生心律失常。多个研究显示，延迟后除极所致的触发活动为该部位的PVC/VT的机制 [<xref ref-type="bibr" rid="hanspub.32645-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.32645-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.32645-ref10">10</xref>]。虽然曾有肺动脉窦起源VAs的报道 [<xref ref-type="bibr" rid="hanspub.32645-ref11">11</xref>]，但既往观点认为RVOT-VAs起源于肺动脉瓣下。事实上，传统采用肺动脉瓣下途径使得一部分RVOT-VAs的标测消融显得较为困难。Liao等 [<xref ref-type="bibr" rid="hanspub.32645-ref4">4</xref>] 提出RVOT-VAs绝大多数起源于肺动脉窦内，并首次提出使用倒“U”法至肺动脉窦内标测消融，消融成功率可达100%。陈海敏等 [<xref ref-type="bibr" rid="hanspub.32645-ref5">5</xref>] 验证了倒“U”法消融有效性和安全性均优于传统瓣下消融。</p><p>本研究发现，因采用倒“U”法，消融导管与组织的贴靠异常稳定，因而在理想靶点处消融，倒“U”法组在平均放电次数、消融达效时间、成功率等指标上均优于传统消融组，有统计学差异。8例传统消融方法失败的患者同次术中继之使用倒“U”法后有7例消融成功，这提示RVOT-VAs的真正起源及最佳消融靶点在肺动脉窦区域，传统流出道仅是VAs传导的出口部位 [<xref ref-type="bibr" rid="hanspub.32645-ref12">12</xref>]。同时肺动脉窦区域空间相对较小，缩小了标测范围，避免了在流出道大范围操作导管标测时引起的心肌穿孔风险，增加了手术安全性。本文1例心包填塞即是在流出道游离壁标测消融时发生的。</p><p>本研究因解剖的定位主要依据Ｘ线影像、三维模型及靶点图特征，未应用腔内超声明确，故在解剖定位上有不足之处。本文另一局限性在于系小样本回顾性研究，需行较大样本量的前瞻性研究进一步确认本文结论。</p></sec><sec id="s8"><title>文章引用</title><p>王小青,王卫明,王梦非,朱帧燕. 肺动脉瓣上消融治疗右心室流出道室性心律失常的临床研究 Clinical Research on Ablation of Ventricular Arrhythmias Originating from Right Ventricular Outflow Tract via Above Pulmonary Valve[J]. 临床医学进展, 2019, 09(10): 1213-1221. https://doi.org/10.12677/ACM.2019.910187</p></sec><sec id="s9"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.32645-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Ouyang, F., Fotuhi, P., Ho, S.Y., et a1. (2002) Repetitive Monomorphic Ventricular Tachycardia Originating from the Aortic Sinus cusp-Electrocardiographic Characterization for Guiding Catheter Ablation. Journal of the American College of Cardiology, 39, 500-508. &lt;br&gt;https://doi.org/10.1016/S0735-1097(01)01767-3</mixed-citation></ref><ref id="hanspub.32645-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Al-Khatib, S.M., Stevenson, W.G., Ackerman, M.J., et al. (2017) 2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary. Journal of the American College of Cardiology, S0735-1097(17)41305-2.</mixed-citation></ref><ref id="hanspub.32645-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Natale, A., Raviele, A., AI-Ahmad, A., et al. (2015) Venice Chart International Consensus US Document on Ventricular Tachycardia/Ventricular Fibrillation Ablation. Journal of Cardiovascular Electrophysiology, 21, 339-379.  
&lt;br&gt;https://doi.org/10.1111/j.1540-8167.2009.01686.x</mixed-citation></ref><ref id="hanspub.32645-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Liao, Z., Zhan, X., Wu, S., et al. (2015) Idiopathic Ventricular Arrhythmias Originating from the Pulmonary Sinus Cusp: Prevalence, Electrocardiograph-ic/Electrophysiological Characteristics, and Catheter Ablation. Journal of the American College of Cardiology, 66, 2633-2644. &lt;br&gt;https://doi.org/10.1016/j.jacc.2015.09.094</mixed-citation></ref><ref id="hanspub.32645-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">陈海敏, 詹贤章, 刘方舟, 黄文祥, 蒙霏霭, 陈烁. 倒“U”法导管消融治疗右心室流出道室性心律失常的有效性及安全性[J]. 岭南心血管病杂志, 2018, 24(5): 534-538.</mixed-citation></ref><ref id="hanspub.32645-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">中国生物医学工程学会心脏起搏与电生理分会, 中华医学会心电生理和起搏分会, “中国心脏起搏与心电生理杂志”编辑部. 射频导管消融治疗快速心律失常指南(修订版)[J]. 中国心脏起搏与心电生理杂志, 2002, 16(2): 81-95.</mixed-citation></ref><ref id="hanspub.32645-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">梁锦军, 黄从新, 杨波. 射频导管消融 洽疗室性早搏的临床评价[J]. 中华心律失常学杂志, 2005, 9(5): 337-340.</mixed-citation></ref><ref id="hanspub.32645-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Calks, D.J., Menz, V. and Schwartzman, D. (1997) Repetitive Monomorphic Tachycardia from the Left Ventricular Outflow Tract Electrocardiographic Patterns Consistent with a Left Ventricular Site of Origin. Journal of the American College of Cardiology, 29, 1023-1027. &lt;br&gt;https://doi.org/10.1016/S0735-1097(97)00004-1</mixed-citation></ref><ref id="hanspub.32645-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Shimoike, E., Ohba, Y. and Yannagi, N. (1998) Radiofrequency Catheter Ablation of Ventricular Outflow Tract Tachycardia: Report of Two Cases. Journal of Cardiovascular Electrophysiology, 9, 196-202.  
&lt;br&gt;https://doi.org/10.1111/j.1540-8167.1998.tb00900.x</mixed-citation></ref><ref id="hanspub.32645-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Yeh, S.J., Wen, M.S. and Wang, C.C. (1997) Adenosine-Sensitive Ventricular Tachycardia from the Antembasal Left Ventricle. Journal of the American College of Cardiology, 30, 1339-1345.  
&lt;br&gt;https://doi.org/10.1016/S0735-1097(97)00291-X</mixed-citation></ref><ref id="hanspub.32645-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Timmermans, C., Rodriguez, L.M., Crijns, H.J., et al. (2003) Idiopathic Left Bundle-Branch Block-Shaped Ventricular Tachycardia May Originate above the Pulmonary Valve. Circulation, 108, 1960-1967. 
&lt;br&gt;https://doi.org/10.1161/01.CIR.0000095026.19339.BB</mixed-citation></ref><ref id="hanspub.32645-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, J., Tang, C., Zhang, Y. and Su, X. (2018) Pulmonary Sinus Cusp Mapping and Ablation: A New Concept and Approach for Idiopathic Right Ventricular Outflow Tract Arrhythmias. HeartRhythm Journal, 15, 38-45. 
&lt;br&gt;https://doi.org/10.1016/j.hrthm.2017.08.007</mixed-citation></ref></ref-list></back></article>